Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 28;15(1):19-22.
doi: 10.4103/jgid.jgid_128_22. eCollection 2023 Jan-Mar.

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine

Shivani Haritay  1 , Rithia Patil  2 , Arif Maldar  3 , Anil Kumar  1 , Vikrama Reddy  1 , Deshna Oswal  1 , Masood Ahmed Tahashildar  2 , Akshay Kolakar  1 , Satish Kabbur  1 , Jang Bahadur Prasad  4 , M S Shivaswamy  5 , Ramesh Paranjape  2 , Mubashir Angolkar  1
Affiliations

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine

Shivani Haritay et al. J Glob Infect Dis. .

Abstract

Introduction: There are limited data available on the long-term presence of SARS-CoV-2-specific binding antibodies and neutralizing antibodies in circulation among the elderly population. This study aims to examine levels of anti-SARS-CoV-2 antibodies in vaccines who have completed at least 6 months since the second vaccine dose. A cross-sectional study was conducted from November 2021 to January 2022 among 199 vaccines aged 60 years and above residing in Belagavi city, who received two doses of the Covishield vaccine.

Methods: Antibody response to SARS-COV-2 virus whole cell antigen was measured by a kit COVID KAWACH IgG Micro LISA (J Mitra and Company, India) in 199 participants who had completed at least 6 months after receiving the second dose of Covishield vaccine. The antibody response was measured as a ratio of optical density (OD) in the participant's sample to the mean OD in negative control test by normal (T/N). Independent Kruskal-Wallis test was applied to test the difference between the T/N ratio by months of vaccination since the second dose and by the age group strata.

Results: The median T/N values among participants who completed 6, 7, 8, and 9 months since the second vaccine dose were 14.17, 10.46, 7.93, and 5.11, respectively, and this decline in T/N values was statistically significant. Antibody response values showed a decline with increasing age for participants in the age strata 60-69, 70-79, and 80 and above, respectively.

Conclusions: A significant decline was observed in antibody response over 9 months supporting the administration of booster dose of vaccine.

Keywords: Antibody waning; COVID-19 vaccine; SARS-CoV-2; booster dose; elderly population; immunoglobulin G antibodies.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Month-wise T/N ratio distribution. T/N: Test by normal
Figure 2
Figure 2
Scatter plot on antibody waning among different age group vaccinees
See this image and copyright information in PMC

References

    1. Coronavirus Disease (COVID-19) Situation Reports. [Last accessed on 2022 Apr 22]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... .
    1. WHO Coronavirus (COVID-19) Dashboard. [Last accessed on 2022 Apr 30]. Available from: https://covid19.who.int .
    1. Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: How age influences the host immune response to coronavirus infections? Front Physiol. 2020;11:571416. - PMC - PubMed
    1. Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. N Engl J Med. 2021;385:e84. - PMC - PubMed
    1. Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, et al. Protection against SARS-CoV-2 after COVID-19 vaccination and previous infection. N Engl J Med. 2022;386:1207–20. - PMC - PubMed